Publication

24 Feb 2014

This paper identifies mechanisms for US-Russian cooperation in reducing the use of highly enriched uranium (HEU) in the production of medical isotopes such as Mo-99. The authors review global trends in the elimination of HEU from Mo-99 production, discuss the future of Mo-99 production in Russia and examine incentives for non-HEU Mo-99 production. Finally, they outline commitments the US and Russia should consider to further their cooperation on the issue.

Download English (PDF, 17 pages, 350 KB)
Author Anton Khlopkov, Miles Pomper, Valeriya Chekina
Series CNS Papers
Publisher James Martin Center for Nonproliferation Studies (CNS)
Copyright © 2014 Monterey Institute of International Studies (MIIS) and Center for Energy and Security Studies (CENESS)
JavaScript has been disabled in your browser